AIDS News and Research

RSS

HIV-positive pregnant women across Africa face discrimination

HIV-positive women across Africa are facing discrimination, with many "say[ing] they have been pressured – even forced – not to have children because people assume they will infect their babies," PRI's The World reports. "Across the continent, there have been organized efforts to prevent HIV-positive women from having children," The World writes, referencing family planning programs aimed at HIV-positive women in Kenya, Namibia and Uganda.

24 Aug 2011

First international conference on developmental, translational and clinical pharmacogenomics

The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.

24 Aug 2011

Scientists show how scaling works in developing fruit fly wings

Weizmann Institute scientists have added a significant piece to the puzzle of scaling - how patterns stay in sync with size as an embryo or organism grows and develops. In a new study appearing in Current Biology, Institute scientists Profs.

24 Aug 2011

AHF criticizes HHS for delays and mistakes in distributing HIV/AIDS funds

Today, AIDS Healthcare Foundation (AHF) criticized the U.S. Department of Health & Human Services (HHS) agency for delays and mistakes in distributing funds through the Ryan White CARE Act, the largest federal program dedicated to providing care and treatment for people living with HIV. Despite an HHS statement to the contrary, the Foundation says that delays in funding are hurting programs that serve people living with HIV/AIDS across the nation.

23 Aug 2011

Survival for patients with HCC increases with radioembolization

Analysis revealed survival for patients with hepatocellular carcinoma (HCC) is achievable using 90Y-resin microsphere radioembolization. The analysis conducted at multiple centers across Europe showed that the procedure is likely to provide survival benefit across different tumor stages, including patients with advanced liver cancer and with limited treatment options.

23 Aug 2011

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

23 Aug 2011

Saint Mark's Cathedral on Capitol Hill to host Seattle AIDS Memorial event

Saint Mark's Cathedral on Capitol Hill will host the Seattle AIDS Memorial on Saturday, September 24, 2011, at 7:00 p.m. Subtitled "30 Years of Sorrow, Comfort and Hope," the memorial commemorates the 30th anniversary of the first HIV/AIDS diagnosis as well as the 25th anniversary of the first AIDS Walk in Seattle.

23 Aug 2011

Should we be screening blood for hepatisi G?

Hepatitis G virus was identified in 1995. Some little research was carried out on the virus and the US Food and Drug Administration (FDA) declared it a non-harmful virus in 1997. Researchers in Saudi Arabia, writing in the International Journal of Immunological Studies present evidence to suggest that this may have been the wrong decision.

22 Aug 2011

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

Today AIDS Healthcare Foundation (AHF) decried the fact that the recent campaign by Gilead Sciences Inc. to obtain approval by the U.S. Food & Drug Administration for Truvada as PrEP (pre-exposure prophylaxis) has led to a "black market" for the drug in Florida.

20 Aug 2011

VOA News examines new drug compound that shows broad-based efficacy in lab tests

VOA News looks at a new drug compound developed by researchers at the Massachusetts Institute of Technology (MIT) that they say has so far "killed every virus it's been tested on in the laboratory." "The drug - known by the acronym DRACO - works by chemically targeting viral-infected cells and prompting them to self-destruct, eliminating the disease in the process," VOA writes.

20 Aug 2011

Isolation of HIV antibodies advances search for AIDS vaccine

A team of researchers has "identified 17 potent antibodies whose discovery opened up valuable pathways in the search for an AIDS vaccine," Agence France-Presse reports.

19 Aug 2011

New book on hemophilia, unintended consequences of medical progress

The Bleeding Disease: Hemophilia and the Unintended Consequences of Medical Progress (John Hopkins University Press) is the new book by NJIT Associate Professor Stephen Pemberton. The book recounts the promising and perilous history of medical and social efforts to manage hemophilia in 20th-century America.

19 Aug 2011

Temple University, URMC partner to translate novel medical research into new drugs

The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have announced a partnership that will help translate novel medical research into new drugs for treating diseases.

19 Aug 2011

Insight into how HIV reservoirs may form

Much like cities organize contingency plans and supplies for emergencies, chronic infectious diseases like HIV form reservoirs that ensure their survival in adverse conditions. But these reservoirs-small populations of viruses or bacteria of a specific type that persist despite attack by the immune system or drug treatment-are not always well understood.

18 Aug 2011

Researchers isolate 17 novel antibodies against HIV

A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.

18 Aug 2011

GeoVax receives NIH-NIAID grant for HIV/AIDS vaccine program

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.

17 Aug 2011

Study of Chicago neighborhoods tracks prevalence of five key public health issues

The south and southwest sides of Chicago suffer the most in terms of residents' health and access to basic health resources, according to a new study of 77 Chicago neighborhoods.

17 Aug 2011

Emotions hinder disease eradication

In a New York Times essay, journalist Donald McNeil writes, "To a doctor, all epidemics are objectively different … But to the mortals they mow down, all epidemics are emotionally alike — an onslaught of fear, awe, repulsion, stigma, denial, rage and blame — and doctors would be foolish to forget that."

17 Aug 2011

Global AIDS funding in 2010 down nearly 10% from previous year, Kaiser/UNAIDS report says

"Spending on the global fight against AIDS fell significantly in 2010 for the first time since the U.S. and other governments began making major donations," according to an annual funding analysis released Monday by the Kaiser Family Foundation and UNAIDS, the Wall Street Journal reports. "All told, governments donated about $6.9 billion in 2010, down 9.7 percent from about $7.6 billion in the prior year, the report said," the newspaper writes.

17 Aug 2011

Experts fear shrinking DOD budget, shifting AFRICOM focus could threaten HIV prevention programs

A shrinking Department of Defense (DOD) budget and a shift in the focus of the U.S. Africa Command (AFRICOM) to "more traditional military threats" to national security, such as "preventing terrorist safe havens on the continent," could affect the department's HIV prevention programs, Stars and Stripes reports.

17 Aug 2011